• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CDDEP released new data documenting alarming rates of bacteria resistant to last-resort antibiotics

Gert van der Hoek

In Memoriam - Editor, Senior Moderator
WASHINGTON, D.C. and NEW DELHI (17 September 2015) -- Researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) released new data today documenting alarming rates of bacteria resistant to last-resort antibiotics that can lead to life-threatening infections across the world. Though wealthy countries still use far more antibiotics per capita, high rates in the low- and middle-income countries where surveillance data is now available?such as India, Kenya, and Vietnam?sound a warning to the world.

For example, in India, 57 percent of the infections caused by Klebsiella pneumoniae, a dangerous superbug found in hospitals, were found to be resistant to one type of last-resort drug in 2014, up from 29 percent in 2008. For comparison, these drugs, known as carbapenems, are still effective against Klebsiella infections in 90 percent of cases in the United States and over 95 percent of cases in most of Europe.


CDDEP?s State of the World?s Antibiotics, 2015 says limiting overuse and misuse of antibiotics are the only sustainable solutions. ?We need to focus 80 percent of our global resources on stewardship and no more than 20 percent on drug development,? said Laxminarayan. ?No matter how many new drugs come out, if we continue to misuse them, they might as well have never been discovered.?


Link to full article

Image is link to the report "State of the World's Antibiotics, 2015" - PDF


 
Back
Top